Meniscus Tears: Can Regenerative Injections Help You Skip Surgery?
Medically reviewed by Dr. Charles Pereyra, MD — Medical Director, Springs Rejuvenation. Last reviewed June 22, 2026.
Written by the Springs Rejuvenation regenerative medicine team from direct clinical experience administering stem cell and exosome protocols at our Aventura, Miami center.
A meniscus tear is one of the most common knee injuries we see, and the question patients ask first is almost always the same: do I really need surgery? For some tears the honest answer is that a surgical repair is the right call. But a meaningful share of degenerative and partial tears may be candidates for a more conservative, regenerative approach that aims to support the knee's own repair environment before anyone reaches for a scalpel.
Why the meniscus is hard to supports on its own
The meniscus is a C-shaped pad of cartilage that cushions the space between your thigh bone and shin bone. Only its outer third has a strong blood supply, which is why the inner portion of the meniscus often struggles to mend after a tear. Regenerative options are studied precisely because they try to add biological signaling to a zone that the body cannot easily reach on its own.
What regenerative injections actually involve
The two most studied options are platelet-rich plasma (PRP) and cell-based or exosome therapy. PRP concentrates the growth-factor-rich portion of your own blood and delivers it to the injured area. Exosome therapy uses signaling vesicles intended to support the local tissue environment. At Springs Rejuvenation these are delivered as part of a tailored plan rather than as a one-size injection, because a small radial tear and a large bucket-handle tear are very different situations.
What the trial data suggests
Studies on PRP for degenerative meniscus changes have reported reduced pain scores and improved function in some patient groups, particularly when the tear is partial and the surrounding cartilage is reasonably intact. Cell-based research is earlier and the trials are smaller, so the evidence should be read with appropriate caution. The realistic framing is that regenerative injections may help certain people delay or avoid an operation, not that they reliably regrow a torn meniscus.
Who is usually a candidate?
Partial or degenerative tears in patients who still have decent cartilage, no locking of the joint, and a desire to try a non-surgical route first tend to be the best fit. A locked knee or a large displaced tear is more likely to need surgical attention, and we will tell you that directly.
How long until I know if it worked?
Most patients are reassessed over a span of several weeks to a few months. Regenerative therapy works gradually, so it is not an overnight fix, and individual results vary considerably.
Is the injection painful?
Discomfort is usually brief and mild. The knee is numbed for the procedure and most people return to light activity the same day, following the aftercare plan your clinician provides.
The Springs approach
We start with imaging and an honest conversation about whether your specific tear is a reasonable candidate for a regenerative plan or whether you would be better served by a surgical consult. If regenerative therapy is appropriate, it is built into a broader knee program rather than offered as a stand-alone shortcut. A free consultation is the simplest way to find out which path fits your knee.
Medical Disclaimer: Stem cell and exosome therapy is not an FDA approved therapy and is considered to be in the experimental stages. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Springs Rejuvenation processes exosomes in an FDA approved lab. Individual results may vary. This content is reviewed for medical accuracy by Dr. Charles Pereyra, MD, Medical Director of Springs Rejuvenation, and is provided for educational purposes only. Always consult a qualified physician.